Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-28

Clinical Trial Update: Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 7-day versus 14-day primaquine regimens used with dihydroartemisinin-piperaquine or a 3-day chloroquine radical cure for Plasmodium viva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)
  • Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
  • Primaquine (primaquine)

Snippet

Sponsor: University of Oxford | Conditions: Vivax Malaria | Phase 3 | Status: COMPLETED